Page last updated: 2024-08-22

ferric chloride and Edema

ferric chloride has been researched along with Edema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Back, DF; Neto, JS; Nogueira, CW; Pesarico, AP; Sartori, G; Zeni, G1
Bachmann, G; Gerriets, T; Heil, M; Kaps, M; Madlener, K; Röttger, C; Stolz, E; Walberer, M; Wessels, T1

Other Studies

2 other study(ies) available for ferric chloride and Edema

ArticleYear
Bis-vinyl selenides obtained via iron(III) catalyzed addition of PhSeSePh to alkynes: synthesis and antinociceptive activity.
    Organic & biomolecular chemistry, 2013, Feb-21, Volume: 11, Issue:7

    Topics: Alkynes; Analgesics; Animals; Catalysis; Chlorides; Dose-Response Relationship, Drug; Edema; Ferric Compounds; Formaldehyde; Male; Mice; Models, Molecular; Molecular Structure; Nociceptive Pain; Organoselenium Compounds

2013
Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
    Stroke, 2005, Volume: 36, Issue:4

    Topics: Abciximab; Angiography; Animals; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Chlorides; Disease Models, Animal; Edema; Enoxaparin; Ferric Compounds; Heparin; Humans; Hydrogen-Ion Concentration; Immunoglobulin Fab Fragments; Intracranial Embolism and Thrombosis; Magnetic Resonance Imaging; Male; Rats; Recombinant Proteins; Sagittal Sinus Thrombosis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis

2005